Top Page
Barclays
(LSE:BARC)
Barclays (BARC) vs. iShares MSCI United Kingdom ETF (EWC)
Barclays Business Overview & Revenue Model
Barclays Earnings Call Summary
Barclays Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.09B | 51.62B | 47.75B | 33.55B | 25.12B | 25.39B |
| Gross Profit | 33.09B | 26.23B | 25.38B | 25.02B | 21.95B | 21.61B |
| EBITDA | 8.55B | 9.81B | 8.34B | 8.73B | 9.87B | 4.80B |
| Net Income | 6.59B | 6.31B | 5.26B | 5.93B | 7.01B | 2.38B |
Balance Sheet | ||||||
| Total Assets | 1.59T | 1.52T | 1.48T | 1.51T | 1.38T | 1.35T |
| Cash, Cash Equivalents and Short-Term Investments | 434.27B | 509.67B | 538.31B | 542.42B | 521.33B | 457.38B |
| Total Debt | 110.53B | 185.75B | 176.55B | 183.37B | 166.59B | 144.02B |
| Total Liabilities | 1.52T | 1.45T | 1.41T | 1.44T | 1.31T | 1.28T |
| Stockholders Equity | 74.88B | 71.82B | 71.20B | 68.29B | 69.05B | 65.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.54B | -2.65B | 28.48B | 47.20B | 56.18B |
| Operating Cash Flow | 0.00 | 7.11B | -927.00M | 30.23B | 48.92B | 57.51B |
| Investing Cash Flow | 0.00 | -17.89B | -23.41B | -21.67B | 4.27B | -18.38B |
| Financing Cash Flow | 0.00 | 784.00M | -1.39B | 696.00M | 107.00M | 2.73B |
Barclays Technical Analysis
Barclays Risk Analysis
Barclays Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | £52.51B | 8.95 | 10.02% | 1.91% | 13.03% | 60.72% | |
68 Neutral | $17.82B | 11.90 | 10.30% | 3.72% | 9.69% | 0.80% | |
| ― | $43.27B | 9.97 | 10.16% | 2.15% | ― | ― | |
82 Outperform | £166.73B | 12.49 | 10.81% | 5.29% | -6.07% | -16.24% | |
74 Outperform | £45.05B | 9.33 | 14.07% | 4.59% | 7.03% | 25.89% | |
73 Outperform | £49.46B | 12.59 | 10.21% | 4.03% | -1.72% | -8.62% | |
70 Outperform | £49.88B | 50.75 | 4.50% | 1.45% | 6.02% | 44.64% |
Barclays Corporate Events
Barclays PLC has announced the repurchase and cancellation of 4,271,076 of its ordinary shares from Citigroup Global Markets Limited as part of its ongoing buy-back program. This move is part of a broader strategy to optimize the company’s capital structure and enhance shareholder value, reducing the total number of shares in circulation and potentially increasing the value of remaining shares. The company’s issued share capital now consists of 14,080,989,168 ordinary shares with voting rights, which stakeholders can use for calculating their interests under regulatory guidelines.
Barclays PLC has disclosed its opening position in the relevant securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a 3.22% interest in Dalata’s ordinary shares and has engaged in various transactions, including purchases and sales, as well as cash-settled derivative transactions. This disclosure is part of regulatory requirements and reflects Barclays’ involvement in the market activities surrounding Dalata Hotel Group, potentially impacting stakeholders and market dynamics.
Barclays PLC has announced the purchase and cancellation of 2,941,838 of its ordinary shares on the London Stock Exchange as part of its ongoing share buy-back program. This move is expected to reduce the total number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests positively. The buy-back program, which began on 30 July 2025, has seen the company acquire a total of 43,057,620 shares, reflecting Barclays’ strategic focus on optimizing its capital structure and enhancing shareholder value.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a 2.93% interest and a 2.88% short position in Dalata’s ordinary shares. This announcement is part of regulatory compliance and provides transparency to stakeholders about Barclays’ involvement in the securities of Dalata Hotel Group, which may impact market perceptions and investor decisions.
Barclays PLC has executed a share buy-back program, purchasing 2,939,758 ordinary shares for cancellation, as part of its ongoing strategy announced on 30 July 2025. This move is expected to reduce the company’s share capital to 14,088,113,738 ordinary shares, potentially impacting shareholder interests and market positioning by altering the shareholding structure.
Barclays PLC announced a transaction involving the disposal of 500,000 ordinary shares by Tristram Roberts, the Group Human Resources Director, through Computershare Investor Services plc. The transaction was conducted on the London Stock Exchange at a price of £3.739 per share, reflecting a strategic financial move that may impact the company’s shareholding structure and market perception.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, revealing a total of 6,056,901 shares owned or controlled, representing 2.86% of the company’s ordinary shares. This disclosure under the Irish Takeover Panel Act indicates Barclays’ strategic positioning in the hotel industry, potentially impacting its investment portfolio and stakeholder interests.
Barclays PLC has announced the repurchase and cancellation of nearly 2.95 million of its ordinary shares as part of a buy-back program initiated on 30 July 2025. This move is part of a broader strategy to manage its capital structure and enhance shareholder value, reducing the total number of shares in circulation to approximately 14.09 billion. The buy-back program reflects Barclays’ commitment to returning capital to shareholders and optimizing its financial position in the competitive banking sector.
Barclays PLC announced a transaction involving Craig Bright, the Group Co-Chief Operating Officer and Barclays Execution Services Co-Chief Executive Officer. The transaction was part of the Barclays Group Share Incentive Plan, where shares were acquired and held on behalf of Craig Bright, including an allocation of matching shares. This transaction reflects the company’s ongoing commitment to aligning management interests with shareholder value, potentially impacting the company’s internal governance and stakeholder confidence.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals that Barclays holds 2.53% of relevant securities and has short positions amounting to 2.48%. This announcement is part of regulatory compliance and provides transparency regarding Barclays’ financial dealings, potentially impacting its strategic positioning and stakeholder interests in the context of the Dalata Hotel Group PLC.
Barclays PLC announced the purchase and cancellation of 4,577,280 of its ordinary shares as part of its ongoing buy-back program. This move, which follows the initial announcement on 30 July 2025, is aimed at reducing the number of shares in circulation, potentially increasing the value of remaining shares and enhancing shareholder value. The cancellation of these shares will adjust the company’s issued share capital to 14,094,002,446 ordinary shares with voting rights, impacting how shareholders calculate their interests under regulatory guidelines.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as part of the Irish Takeover Panel’s requirements. The disclosure reveals that Barclays holds 2.55% in relevant securities and 2.50% in short positions, indicating its significant involvement in the ongoing dealings with Dalata Hotel Group. This disclosure is crucial for stakeholders as it provides transparency into Barclays’ financial strategies and positions within the market.
Barclays PLC has repurchased and canceled 4,380,568 of its ordinary shares as part of a buy-back program announced in July 2025. This move reduces the company’s share capital to 14,098,579,726 ordinary shares, impacting shareholder calculations under FCA rules and potentially strengthening the company’s market position by reducing share dilution.
Barclays PLC has disclosed its dealings in the securities of Dalata Hotel Group PLC, as required under Irish Takeover Panel rules. The disclosure reveals that Barclays holds a 2.54% interest and a 2.49% short position in Dalata’s ordinary shares, indicating a significant stake and involvement in the company’s securities. This activity reflects Barclays’ strategic interest in the hospitality sector, potentially impacting its market positioning and stakeholder relations.
Barclays PLC has executed a share buy-back program, purchasing 3,031,481 of its ordinary shares for cancellation on the London Stock Exchange. This move is part of a broader buy-back initiative announced on July 30, 2025, aimed at reducing the company’s share capital and potentially increasing shareholder value. The cancellation of these shares will adjust the company’s issued share capital to 14,101,864,881 ordinary shares with voting rights, impacting how shareholders calculate their interests under regulatory guidelines.
Barclays PLC has disclosed its current interests and short positions in the securities of Dalata Hotel Group PLC, as part of the Irish Takeover Panel’s regulations. This disclosure highlights Barclays’ significant stake and trading activities in Dalata’s shares, reflecting its strategic positioning and potential influence in the hospitality sector.
Barclays PLC has announced the purchase and cancellation of 4,391,165 ordinary shares as part of its ongoing share buy-back program. This move is expected to reduce the company’s share capital, potentially increasing the value of remaining shares and influencing shareholder interests under regulatory guidelines.
Barclays PLC announced a transaction involving the disposal of shares by Cathal Deasy, the Global Co-Head of Investment Banking. The transaction, conducted on the London Stock Exchange, involved the sale of 33,374 shares at a price of £3.618 per share. This disclosure highlights the ongoing management of shareholdings by key personnel, which may impact investor perceptions and the company’s stock market performance.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as required by the Irish Takeover Panel rules. The disclosure indicates Barclays holds a 2.36% interest and a 2.31% short position in Dalata’s ordinary shares, reflecting its strategic financial positioning in the market. This announcement may influence stakeholders’ perception of Barclays’ investment strategy and its impact on the hospitality sector.
Barclays PLC has executed a share buy-back program, purchasing 4,402,615 of its ordinary shares for cancellation, as part of a broader initiative announced in July 2025. This move is expected to reduce the total number of shares in circulation, potentially enhancing shareholder value and reflecting the company’s strategic focus on optimizing its capital structure.
Barclays PLC has disclosed its position in the securities of Dalata Hotel Group PLC, as required by the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a 2.29% interest in Dalata’s ordinary shares and has engaged in various purchase and sale transactions. This announcement highlights Barclays’ strategic financial maneuvers in the market, potentially impacting its investment portfolio and signaling its interest in the hospitality sector.
Barclays PLC has announced the purchase and cancellation of 4,405,641 of its ordinary shares from Citigroup Global Markets Limited as part of its ongoing share buy-back program. This action is part of a strategy to reduce the number of shares in circulation, potentially increasing the value of remaining shares and demonstrating the company’s commitment to returning value to shareholders. Following the cancellation, Barclays’ issued share capital will consist of 14,113,682,340 ordinary shares with voting rights, which stakeholders can use to assess their shareholdings under regulatory rules.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel rules. The disclosure reveals that Barclays holds a 2.22% interest in Dalata’s ordinary shares and has a 2.18% short position. This announcement is part of regulatory compliance and reflects Barclays’ active engagement in managing its investment portfolio, potentially impacting its strategic positioning in the market.
Barclays PLC has announced the purchase and cancellation of 4,429,563 of its ordinary shares as part of its ongoing share buy-back program. This move, which follows the initial buy-back announcement on 30 July 2025, is aimed at reducing the total number of shares in circulation, thereby potentially increasing the value of remaining shares and enhancing shareholder value. The company’s issued share capital now consists of 14,118,084,200 ordinary shares with voting rights, and this adjustment is significant for shareholders and stakeholders monitoring their interest in the company.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, revealing ownership of 1.94% of relevant securities and short positions amounting to 1.91%. This disclosure is part of the regulatory requirements under the Irish Takeover Panel rules, indicating Barclays’ strategic financial maneuvers and potential influence in the ongoing market activities related to Dalata Hotel Group PLC.
Barclays PLC has announced that as of July 31, 2025, its issued share capital comprises 14,122,464,513 ordinary shares with voting rights, with no shares held in treasury. This information is crucial for shareholders and others with notification obligations to determine if they need to notify their interest changes in accordance with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.
Barclays PLC announced the purchase and cancellation of 2,300,707 of its ordinary shares as part of a buy-back program initiated on 30 July 2025. This move is aimed at reducing the number of shares in circulation, potentially increasing the value of remaining shares and improving shareholder returns. The company’s issued share capital now stands at 14,122,464,513 ordinary shares with voting rights, which stakeholders can use for calculating their interests under regulatory guidelines.
Barclays PLC announced transactions involving the disposal and acquisition of shares by key managerial personnel and non-executive directors. This includes disposals by Stephen Dainton, Taalib Shaah, and Taylor Wright, and acquisitions by Robert Berry, Dawn Fitzpatrick, and Mary Francis, reflecting the company’s policy of directors purchasing shares as part of their compensation. These transactions, conducted on the London Stock Exchange, highlight the ongoing financial strategies and governance practices within Barclays, potentially impacting shareholder interests and market perceptions.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as part of the Irish Takeover Panel’s regulations. The disclosure reveals Barclays’ ownership and control of 1.93% of Dalata’s ordinary shares, alongside various derivative positions. This announcement highlights Barclays’ strategic financial maneuvers in the market, potentially impacting its investment portfolio and stakeholder interests.
Barclays PLC has disclosed its positions and dealings in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals Barclays’ interests and short positions in Dalata’s securities, indicating a strategic financial engagement with the hotel group, which could influence market perceptions and stakeholder decisions.
Barclays PLC has disclosed its dealings in the securities of Dalata Hotel Group PLC, revealing a mix of interests and short positions in ordinary shares and cash-settled derivatives. This disclosure, made under Rule 8.3 of the Irish Takeover Panel Act, highlights Barclays’ strategic financial maneuvers in the hospitality sector, potentially impacting its market positioning and stakeholder interests.
Barclays PLC announced the completion of a share buy-back program, purchasing over 2.3 million of its ordinary shares for cancellation. This move is part of its strategy to optimize capital structure and enhance shareholder value, reducing the total number of shares in circulation and potentially increasing earnings per share.
Barclays PLC has published a Supplemental Information Memorandum for its AUD Debt Issuance Programme, updating the original document from March 2025. This release is significant as it provides stakeholders with updated information on the company’s debt issuance strategy, potentially impacting its financial operations and market positioning.
Barclays PLC has announced the publication of a base prospectus supplement for its Debt Issuance Programme, approved by the Financial Conduct Authority. This development is a significant step in Barclays’ financial operations, potentially impacting its debt issuance strategy and offering stakeholders updated information on its financial instruments.
Barclays PLC, a major player in the financial services industry, has disclosed its positions in the securities of Dalata Hotel Group PLC as part of the Irish Takeover Panel’s regulations. The disclosure reveals Barclays’ interests and short positions in Dalata’s ordinary shares, with a total interest of 1.89% and short positions of 1.86%. This announcement provides transparency into Barclays’ investment activities and compliance with regulatory requirements, potentially impacting stakeholders’ perceptions of both Barclays and Dalata Hotel Group.
Barclays PLC has announced the commencement of a share buy-back program, aiming to purchase up to £1,000 million worth of its ordinary shares to reduce its share capital. This move, executed through Citigroup Global Markets Limited, is intended to enhance shareholder value by cancelling the repurchased shares, and it reflects Barclays’ strategic focus on optimizing its capital structure and returning value to its shareholders.
Barclays PLC has disclosed its positions and dealings in the securities of Dalata Hotel Group PLC as part of the Irish Takeover Panel’s requirements. The disclosure reveals Barclays’ interests in ordinary shares and derivatives, highlighting its strategic financial maneuvers in the context of the takeover rules. This announcement is significant as it underscores Barclays’ active involvement in the market and could influence stakeholders’ perceptions and decisions regarding the Dalata Hotel Group PLC.
Barclays PLC announced its interim results for the six months ending 30 June 2025, highlighting the company’s financial performance across various business segments. The announcement provides insights into the company’s risk management strategies and financial health, emphasizing the use of non-IFRS performance measures for better comparison of business performance. Barclays continues to engage with investors globally to discuss these results and other strategic matters, underscoring its active presence in the debt capital markets.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals that Barclays holds 1.96% in relevant securities and 1.95% in short positions, indicating a significant stake in Dalata’s securities. This move could impact the market perception of Dalata Hotel Group and influence other stakeholders’ decisions.
Barclays PLC has disclosed its significant shareholding in Dalata Hotel Group PLC, with interests and short positions representing 1.93% of the relevant securities. The disclosure indicates Barclays’ active engagement in the market through various transactions, including purchases and sales of ordinary shares and cash-settled derivatives. This activity reflects Barclays’ strategic positioning in the market and could influence its investment strategy and stakeholder interests.
Barclays PLC has completed its share buy-back program, initially announced in February 2025, by purchasing and cancelling 3,512,480 ordinary shares on the London Stock Exchange. This move is part of a larger initiative where the company repurchased a total of 324,428,384 shares, amounting to approximately £1 billion, which is expected to impact its capital structure and shareholder value by reducing the number of shares outstanding.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a 1.91% interest and a 1.92% short position in Dalata’s €0.01 ordinary shares. This announcement highlights Barclays’ involvement in the financial dealings related to Dalata Hotel Group, which may influence its market positioning and stakeholder interests.
Barclays PLC announced the purchase and cancellation of 2,520,000 of its ordinary shares as part of its ongoing buy-back program, initially announced in February 2025. This move reduces the company’s issued share capital to 14,130,585,754 shares, impacting shareholders’ calculations under the FCA’s rules, and reflects Barclays’ strategic financial management to enhance shareholder value.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, holding 1.55% in both interests and short positions. This disclosure highlights Barclays’ active engagement in the market, potentially impacting its investment strategy and stakeholder interests in the hospitality sector.
Barclays PLC has announced the purchase and cancellation of 2,505,660 of its ordinary shares as part of its ongoing share buy-back program. This move is part of a broader strategy to manage its share capital and potentially enhance shareholder value, with implications for its market positioning and stakeholder interests.
Barclays PLC has disclosed its opening position and dealings in the relevant securities of Dalata Hotel Group PLC under Rule 8.3 of the Irish Takeover Panel Act, 1997. The disclosure reveals that Barclays holds a 1.45% interest and a 1.46% short position in Dalata’s €0.01 ordinary shares. This announcement highlights Barclays’ strategic positioning and interest in the hospitality sector, potentially impacting its investment portfolio and stakeholder interests.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as required by the Irish Takeover Panel rules. The disclosure reveals that Barclays holds a 1.36% interest in Dalata’s ordinary shares, reflecting its strategic positioning in the market. This move could have implications for stakeholders, indicating Barclays’ active engagement in the hospitality sector through financial instruments.
Barclays PLC announced the purchase and cancellation of 1,745,000 of its ordinary shares as part of its ongoing buy-back program, initially announced in February 2025. This move is part of a broader strategy to manage its share capital, with the total number of shares purchased since the program’s inception reaching 315,890,244. The cancellation of these shares will adjust the company’s issued share capital, impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has disclosed its current interests and short positions in the securities of Dalata Hotel Group PLC, as per the Irish Takeover Panel’s requirements. The disclosure reveals that Barclays holds a 1.38% interest in Dalata’s ordinary shares, with both long and short positions. This announcement is significant as it provides transparency in Barclays’ dealings with Dalata, potentially impacting stakeholders’ perceptions and the market dynamics surrounding Dalata’s securities.
Barclays PLC has disclosed its opening position and dealings in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a 1.36% interest in Dalata’s ordinary shares and has engaged in various purchase and sale transactions. This disclosure is part of regulatory requirements and provides transparency in Barclays’ investment activities, potentially impacting its strategic positioning in the market.
Barclays PLC announced the repurchase and cancellation of 1,776,394 of its ordinary shares on the London Stock Exchange, as part of its ongoing buy-back program initiated in February 2025. This transaction is part of a broader strategy to manage the company’s capital structure and improve shareholder value, with the total shares repurchased since the program’s inception reaching 312,409,361. The cancellation of these shares will adjust the company’s issued share capital, potentially impacting shareholder calculations under regulatory guidelines.
Barclays PLC has disclosed its opening position and dealings in the securities of Dalata Hotel Group PLC, as required under Rule 8.3 of the Irish Takeover Panel Act. The disclosure indicates that Barclays holds a 1.34% interest and a 1.35% short position in Dalata’s ordinary shares. This announcement highlights Barclays’ active role in the financial markets and its strategic interest in Dalata, potentially impacting stakeholders by influencing market perceptions and investment strategies.
Barclays PLC has announced the purchase and cancellation of 1,777,000 of its ordinary shares as part of a buy-back program initiated in February 2025. This move reduces the company’s issued share capital to 14,140,868,691 shares, potentially impacting shareholder calculations under FCA rules. The buy-back reflects Barclays’ strategy to manage its capital structure and return value to shareholders.
Barclays PLC has disclosed its dealings in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals that Barclays holds interests and short positions in Dalata’s ordinary shares, totaling 1.15% of the relevant securities. This announcement is part of regulatory compliance and provides transparency regarding Barclays’ financial activities in relation to Dalata, which could impact stakeholders’ perception of the company’s market strategies.
Barclays PLC has executed a share buy-back program, purchasing 1,773,000 of its ordinary shares on the London Stock Exchange for cancellation. This move is part of a broader buy-back initiative announced earlier in the year, aimed at reducing the total number of shares in circulation, which now stands at 14,142,645,691. The cancellation of shares is expected to impact the company’s capital structure and could influence shareholder value, aligning with regulatory requirements under the Market Abuse Regulation.
Barclays PLC has announced the purchase and cancellation of 1,720,000 of its ordinary shares as part of its ongoing share buy-back program. This move is part of a broader strategy to manage capital and enhance shareholder value, with the company’s issued share capital now consisting of 14,144,399,449 ordinary shares with voting rights.
Barclays PLC has executed a share buy-back program, purchasing 4,534,000 of its ordinary shares for cancellation on the London Stock Exchange. This move is part of a broader buy-back initiative announced earlier in February 2025, which has seen the company repurchase a total of 303,572,967 shares. The cancellation of these shares will reduce the company’s issued share capital to 14,147,879,778 ordinary shares, potentially impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has executed a share buy-back transaction, purchasing 4,536,117 of its ordinary shares from J.P. Morgan Securities plc for cancellation. This move is part of a broader buy-back program initiated in February 2025, aimed at reducing the number of shares in circulation, thereby potentially increasing shareholder value and adjusting the company’s capital structure.
Barclays PLC has announced the purchase and cancellation of 2,626,677 of its ordinary shares as part of its ongoing buy-back program, initially announced in February 2025. This move is part of a larger strategy to optimize its capital structure, with the total shares repurchased since the program’s inception reaching 294,502,850. The cancellation of these shares will adjust the company’s issued share capital to 14,156,918,945 ordinary shares, impacting shareholder calculations under regulatory guidelines.
Barclays PLC announced a transaction involving Craig Bright, Co-Group COO and Co-CEO of Barclays Execution Services Limited, who acquired ordinary shares through the Barclays Group Share Incentive Plan. This acquisition, which includes matching shares, was conducted outside a trading venue at a price of £3.311 per share for a total of 92 shares. This transaction highlights the company’s ongoing efforts to align managerial interests with shareholder value, potentially impacting stakeholder confidence and market perception.
Barclays PLC announced the repurchase and cancellation of 1,823,507 of its ordinary shares as part of its ongoing buy-back program, initially announced in February 2025. This move reduces the total number of shares outstanding, potentially increasing the value of remaining shares and reflecting the company’s commitment to returning value to shareholders.
Barclays PLC announced the purchase and cancellation of 4,633,680 of its ordinary shares on the London Stock Exchange as part of its ongoing share buy-back program. This move is part of a broader strategy to enhance shareholder value, as evidenced by the total purchase of 290,052,666 shares since the program’s inception in February 2025. The cancellation of these shares will adjust the company’s issued share capital, impacting shareholder calculations under regulatory guidelines.
Barclays PLC has announced the purchase and cancellation of 4,728,000 of its ordinary shares as part of a buy-back program initiated on 14 February 2025. This move is part of a broader strategy to manage its capital structure, with the company having acquired a total of 285,418,986 shares since the program’s inception. The cancellation of these shares will adjust the company’s issued share capital to 14,164,748,734 ordinary shares with voting rights, impacting shareholder calculations under FCA’s rules.
Barclays PLC has executed a share buy-back program, purchasing 4,570,000 of its ordinary shares for cancellation, as part of a strategy announced earlier in the year. This move is intended to reduce the number of shares in circulation, potentially enhancing shareholder value and aligning with regulatory requirements. The completion of this transaction brings the total number of shares repurchased since February 2025 to 280,690,986, reflecting the company’s commitment to optimizing its capital structure.
Barclays PLC announced the purchase and cancellation of 1,809,954 of its own ordinary shares as part of a buy-back program initiated in February 2025. This move is part of a larger strategy to reduce the number of shares in circulation, potentially increasing the value of remaining shares and strengthening shareholder value. The cancellation will result in an updated issued share capital of 14,174,032,966 ordinary shares with voting rights, which stakeholders can use as a reference for their interest calculations.
Barclays PLC has announced that as of 30 June 2025, its issued share capital consists of 14,175,829,645 Ordinary shares with voting rights, with none held in Treasury. This information is crucial for shareholders and others with notification obligations under the FCA’s Disclosure Guidance and Transparency Rules, as it serves as the denominator for calculating any required notifications of interest changes in Barclays PLC.
Barclays PLC announced the purchase and cancellation of 1,802,000 of its ordinary shares as part of its ongoing buy-back program. This move is part of a broader strategy to optimize capital structure and enhance shareholder value, reducing the total number of shares outstanding and potentially increasing earnings per share. The cancellation will adjust the company’s issued share capital to 14,175,829,645 ordinary shares, which will be used for calculating shareholder interests under regulatory guidelines.
Barclays PLC announced the purchase and cancellation of 2,657,000 of its ordinary shares as part of a buy-back program initiated in February 2025. This transaction, executed through J.P. Morgan Securities plc, is part of a broader effort that has seen the company repurchase a total of 272,509,032 shares. The cancellation of these shares will adjust the company’s issued share capital to 14,177,615,300 ordinary shares, impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has repurchased and canceled 1,838,000 of its ordinary shares as part of its ongoing buy-back program, initially announced in February 2025. This move reduces the company’s issued share capital to 14,180,272,300 shares, potentially impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC announced the purchase and cancellation of 1,825,655 of its ordinary shares as part of its ongoing buy-back program, which began in February 2025. This move reduces the company’s issued share capital to 14,182,099,898 ordinary shares, potentially impacting shareholder calculations under FCA rules and reflecting Barclays’ strategy to manage its capital structure and enhance shareholder value.
Barclays PLC issued a correction to a previous announcement regarding a transaction by Taylor Wright, the Global Co-Head of Investment Banking. The correction involved the date of a share transaction related to the delivery of shares as part of Wright’s fixed remuneration. The shares, delivered under a trading plan, are subject to a holding period with restrictions lifting over five years. Additionally, shares were sold to cover tax liabilities, with both transactions occurring on June 20, 2025, on the London Stock Exchange.
Barclays PLC has announced the purchase and cancellation of 2,762,000 of its ordinary shares as part of a buy-back program initiated in February 2025. This move is intended to reduce the overall number of shares in circulation, which may enhance shareholder value and impact the company’s market positioning by potentially increasing earnings per share.
Barclays PLC announced transactions involving its senior executives, who received shares as part of their fixed remuneration. These shares, delivered under pre-established trading plans, are subject to a holding period with restrictions lifting over five years. The transactions were conducted on the London Stock Exchange, and some shares were sold to cover tax liabilities. This announcement reflects Barclays’ ongoing commitment to aligning executive compensation with shareholder interests and regulatory compliance.
Barclays PLC announced the purchase and cancellation of 1,883,000 of its ordinary shares as part of its ongoing buy-back program, initially announced in February 2025. This move is part of a broader strategy to manage its capital structure, potentially impacting shareholder value and market perception by reducing the number of shares in circulation, thereby increasing the value of remaining shares.
Barclays PLC has executed a share buy-back program, purchasing and cancelling 2,755,000 of its ordinary shares on the London Stock Exchange. This move, part of a larger buy-back initiative announced earlier in the year, aims to reduce the total number of shares in circulation, potentially enhancing shareholder value and optimizing capital structure. The cancellation of these shares will adjust the company’s issued share capital to 14,188,487,920 shares with voting rights, impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has executed a share buy-back program, purchasing 1,870,803 of its ordinary shares for cancellation, as part of a previously announced plan. This move reduces the total number of shares in circulation, potentially increasing the value of remaining shares and reflecting the company’s strategy to enhance shareholder value.
Barclays PLC announced the repurchase and cancellation of 1,896,000 of its ordinary shares as part of its ongoing buy-back program, initially announced in February 2025. This transaction, conducted through J.P. Morgan Securities plc, aims to reduce the company’s share capital, with the total issued share capital now consisting of 14,193,111,990 ordinary shares. The buy-back initiative reflects Barclays’ strategy to enhance shareholder value and optimize its capital structure, potentially impacting shareholder interests and market perception.
Barclays PLC has announced the issuance of AUD 1 billion in Fixed-to-Floating and Floating Rate Senior Debt Instruments under its AUD Debt Issuance Programme. This strategic move aims to bolster Barclays’ financial position and liquidity, potentially enhancing its market competitiveness and providing stakeholders with insights into the company’s future financial strategies.
Barclays PLC announced the purchase and cancellation of 2.7 million of its ordinary shares as part of its ongoing share buy-back program. This action reduces the total number of shares in circulation, potentially increasing the value of remaining shares and reflecting the company’s strategy to return value to shareholders.
Barclays PLC has announced the purchase and cancellation of 2,745,000 of its ordinary shares as part of its ongoing share buy-back program. This move, which follows a previous announcement in February 2025, is aimed at reducing the company’s share capital and potentially enhancing shareholder value. The transaction was executed by J.P. Morgan Securities plc, and the cancellation of these shares will adjust the company’s issued share capital to 14,197,681,501 ordinary shares with voting rights. This strategic buy-back reflects Barclays’ commitment to optimizing its capital structure and could have implications for shareholder interest calculations under regulatory guidelines.
Barclays PLC has announced the purchase and cancellation of 2,717,000 ordinary shares as part of its ongoing buy-back program, which began on 14 February 2025. This move reduces the company’s issued share capital to 14,200,402,167 ordinary shares with voting rights, potentially impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has announced the purchase and cancellation of 4,767,000 of its ordinary shares on the London Stock Exchange, as part of its ongoing share buy-back program initiated in February 2025. This move reduces the company’s issued share capital to 14,203,117,000 ordinary shares, potentially impacting shareholder calculations under FCA’s rules, and reflects Barclays’ strategy to manage its capital structure and enhance shareholder value.
Barclays PLC has announced the purchase and cancellation of 4,763,000 of its ordinary shares on the London Stock Exchange as part of its ongoing buy-back program initiated in February 2025. This move is part of a broader strategy to optimize the company’s capital structure, and following the cancellation, Barclays’ issued share capital will consist of 14,207,876,446 ordinary shares with voting rights. The buy-back program reflects Barclays’ commitment to returning value to shareholders and may impact the company’s shareholding structure and market perception.
Barclays PLC announced a transaction involving Denny Nealon, the CEO of Barclays US Consumer Bank and Barclays Bank Delaware. Nealon received 38 American Depositary Shares (ADSs) as part of the Global Share Purchase Plan, with each ADS priced at $18.13. This transaction highlights Barclays’ ongoing efforts to align managerial interests with shareholder value, potentially impacting the company’s market perception and stakeholder relations.
Barclays PLC has executed a share buy-back program, purchasing 1,834,741 ordinary shares for cancellation on the London Stock Exchange, as part of its ongoing strategy announced in February 2025. This move reduces the total number of shares in circulation, potentially increasing shareholder value and reflecting the company’s commitment to efficient capital management.
Barclays PLC has disclosed its positions and dealings in the securities of Dalata Hotel Group PLC, as required under Rule 8.3 of the Irish Takeover Panel Act. The disclosure highlights Barclays’ interests and short positions in Dalata’s securities, reflecting a strategic financial maneuver that could influence its market position and stakeholder interests.
Barclays PLC has executed a share buy-back program, purchasing 1,840,000 of its ordinary shares for cancellation, with prices ranging from 329.8500p to 333.3500p per share. This move, part of a larger buy-back initiative announced in February 2025, reduces the company’s share capital to 14,214,436,739 shares, potentially impacting shareholder interests and market perceptions of the company’s financial health.
Barclays PLC has disclosed its positions in the securities of Dalata Hotel Group PLC, as required under Rule 8.3 of the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a total of 1,695,102 ordinary shares, representing 0.80% of Dalata’s relevant securities. This announcement is part of the regulatory requirements for transparency in securities dealings, ensuring stakeholders are informed about significant positions held by major financial entities.
Barclays PLC has announced the purchase and cancellation of 4,675,000 of its ordinary shares on the London Stock Exchange, as part of its ongoing buy-back program initiated in February 2025. This action reduces the company’s issued share capital to 14,214,988,385 ordinary shares, potentially impacting shareholder calculations under FCA’s rules, and reflects Barclays’ strategy to enhance shareholder value.
Barclays PLC has disclosed its opening position and dealings in the securities of Dalata Hotel Group PLC under the Irish Takeover Panel Act. The disclosure reveals Barclays’ interests and short positions in Dalata’s securities, highlighting a total interest of 0.81% in relevant securities. This announcement is part of regulatory compliance and provides transparency regarding Barclays’ involvement in the potential takeover scenario.
Barclays PLC has disclosed its opening position and dealings in the securities of Dalata Hotel Group PLC, as per the Irish Takeover Panel’s requirements. This disclosure reveals Barclays’ interests and short positions in Dalata’s ordinary shares, indicating a strategic financial maneuver that could impact its investment portfolio and influence market perceptions of both companies.
Barclays PLC announced the purchase and cancellation of 2,670,038 ordinary shares as part of its ongoing share buy-back program, initially announced in February 2025. This move is part of a larger strategy to reduce the number of shares in circulation, potentially increasing shareholder value and affecting the company’s market positioning by altering the share capital structure.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as required by the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a total of 2,101,311 shares, representing 0.99% of the relevant securities, and has engaged in various transactions involving ordinary shares and cash-settled derivatives. This announcement highlights Barclays’ strategic positioning and involvement in the market, potentially impacting its stakeholders and market perception.
Barclays PLC has announced the purchase and cancellation of 2,685,007 of its ordinary shares on the London Stock Exchange as part of its ongoing share buy-back program initiated in February 2025. This move is part of a broader strategy to reduce the number of shares in circulation, potentially increasing the value of remaining shares and improving shareholder returns. Following this transaction, Barclays’ total issued share capital will consist of 14,224,954,424 ordinary shares with voting rights, which stakeholders can use for notification obligations under regulatory guidelines.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel rules. The disclosure reveals that Barclays holds a total of 2,419,833 shares, representing 1.14% of Dalata’s ordinary shares, and has engaged in various purchase and sale transactions. This announcement highlights Barclays’ active involvement in the market and could influence stakeholders’ perceptions of its strategic interests in the hospitality sector.
Barclays PLC has announced the repurchase and cancellation of 1,862,500 ordinary shares as part of its ongoing share buy-back program initiated in February 2025. This move reduces the company’s issued share capital to 14,227,614,389 ordinary shares, potentially impacting shareholder calculations under FCA regulations. The buy-back program reflects Barclays’ strategy to enhance shareholder value and optimize its capital structure.
Barclays PLC has disclosed its current position in the securities of Dalata Hotel Group PLC, as required under Rule 8.3 of the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a total of 1.15% in relevant securities and 1.14% in short positions of Dalata Hotel Group PLC. This announcement provides transparency on Barclays’ investment stance and could influence market perceptions and stakeholder decisions regarding the ongoing or potential corporate activities involving Dalata Hotel Group.
Barclays PLC has announced that as of 31 May 2025, its issued share capital comprises 14,229,471,353 Ordinary shares with voting rights, with none held in Treasury. This figure is crucial for shareholders and others with notification obligations to determine their interest in the company under the FCA’s Disclosure Guidance and Transparency Rules.
Barclays PLC has announced the purchase and cancellation of 2,695,603 of its ordinary shares on the London Stock Exchange as part of its ongoing buy-back program. This strategic move is expected to impact the company’s share capital structure, reducing the total number of shares to 14,229,471,353, thereby potentially enhancing shareholder value and adjusting market positioning.
Barclays PLC has disclosed its positions in the securities of Dalata Hotel Group PLC, as required under Rule 8.3 of the Irish Takeover Panel Act. The disclosure reveals that Barclays holds interests and short positions in Dalata’s ordinary shares, amounting to a total of 2,397,293 shares representing 1.13% of the relevant securities. This announcement is part of regulatory compliance and may impact stakeholders by providing transparency about Barclays’ involvement in Dalata’s securities, potentially influencing market perceptions and investment decisions.
Barclays PLC has announced the purchase and cancellation of 2,716,000 ordinary shares as part of its ongoing share buy-back program. This move, aimed at reducing the number of shares in circulation, will adjust the company’s issued share capital to 14,232,164,533 ordinary shares with voting rights, potentially impacting shareholder calculations under the FCA’s rules.
Barclays PLC has disclosed its positions and dealings in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals Barclays’ interests and short positions in Dalata’s ordinary shares, with a total of 2,359,782 shares representing 1.12% of interests and 2,350,141 shares representing 1.11% of short positions. This announcement is significant for stakeholders as it provides transparency into Barclays’ investment activities and may impact market perceptions of Dalata Hotel Group PLC.
Barclays PLC announced the purchase and cancellation of 1,859,000 of its ordinary shares as part of a buy-back program initiated in February 2025. This move reduces the company’s issued share capital to 14,234,880,533 shares, potentially impacting shareholder calculations under FCA rules. The buy-back program reflects Barclays’ strategy to manage its capital structure and return value to shareholders.
Barclays PLC has disclosed its opening position in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure indicates Barclays holds a 1.11% interest in Dalata’s ordinary shares, reflecting its strategic investments and trading activities. This move could influence the market dynamics and stakeholder interests in the hospitality sector.
Barclays PLC has repurchased 1,887,000 of its ordinary shares on the London Stock Exchange as part of its share buy-back program announced earlier in February 2025. This move is intended to cancel the repurchased shares, reducing the total issued share capital to 14,236,739,533 ordinary shares with voting rights. The buy-back program, which aims to optimize the company’s capital structure, has seen Barclays purchase a total of 211,796,830 shares at an average price of 295.1982p per share, reflecting the company’s strategic focus on enhancing shareholder value.
Barclays PLC has announced the publication of an Offering Circular related to the issuance of £1 billion in Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities. This move is part of Barclays’ strategic financial operations, potentially impacting its capital structure and providing insights into its approach to managing financial resources and obligations.
Barclays PLC has announced the issuance of CNY 700,000,000 3.120% Fixed Rate Senior Callable Notes due in 2030 under its Debt Issuance Programme. This move is part of Barclays’ strategic financial operations, potentially enhancing its liquidity position and offering investment opportunities to stakeholders in the fixed income market.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals Barclays’ strategic positioning in Dalata’s securities, potentially impacting market perceptions and stakeholder decisions regarding Dalata’s ongoing business operations.
Barclays PLC has announced the purchase and cancellation of 4,718,000 of its ordinary shares as part of a buy-back program initiated in February 2025. This move is part of a larger strategy that has seen the company repurchase a total of 209,909,830 shares, potentially impacting shareholder value and market perception by reducing the number of shares in circulation.
Barclays PLC has disclosed its interest and short positions in the securities of Dalata Hotel Group PLC, as part of the Irish Takeover Panel’s requirements. The disclosure reveals Barclays’ ownership and control of relevant securities, cash-settled derivatives, and stock-settled derivatives, reflecting its strategic positioning and potential influence in the ongoing dealings with Dalata Hotel Group. This announcement may impact stakeholders by highlighting Barclays’ active involvement in the market and its strategic interests in the hospitality sector.
Barclays PLC has disclosed its interest and short positions in the securities of Dalata Hotel Group PLC, as required by the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a total of 2,344,380 relevant securities, representing 1.11% of interests and 2,397,420 securities representing 1.13% of short positions. This announcement is part of regulatory compliance and reflects Barclays’ active engagement in the market, potentially impacting its strategic positioning and stakeholder interests.
Barclays PLC has announced the repurchase and cancellation of 2,683,000 of its ordinary shares on the London Stock Exchange, as part of its ongoing buy-back program initiated in February 2025. This strategic move aims to reduce the total number of shares in circulation, thereby potentially increasing the value of remaining shares and enhancing shareholder value. The company’s issued share capital post-cancellation will consist of 14,243,319,257 ordinary shares with voting rights, which stakeholders can use for notification obligations under regulatory guidelines.
Barclays PLC has disclosed its positions in the securities of Dalata Hotel Group PLC, as required under Rule 8.3 of the Irish Takeover Panel Act. The disclosure reveals Barclays’ interests and short positions in Dalata’s securities, with a total of 2,347,340 securities owned or controlled and 2,402,470 in short positions. This announcement highlights Barclays’ active involvement in the market and its strategic positioning in relation to Dalata Hotel Group, potentially impacting stakeholders’ perceptions and the company’s market strategy.
Barclays PLC announced the purchase and cancellation of 2,675,000 of its ordinary shares as part of its ongoing buy-back program. This move, which follows a previous announcement in February 2025, aims to reduce the total number of shares in circulation, thereby potentially increasing the value of remaining shares and enhancing shareholder value. The transaction reflects Barclays’ strategic focus on optimizing its capital structure and returning value to shareholders, while also adhering to regulatory requirements.
Barclays PLC has disclosed its positions in the securities of Dalata Hotel Group PLC under the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a 1.11% interest and a 1.14% short position in Dalata’s securities. This announcement is part of regulatory compliance and provides transparency in Barclays’ investment activities, potentially impacting stakeholder perceptions and market dynamics in the hospitality sector.
Barclays PLC has executed a share buy-back program, purchasing 1,861,585 of its ordinary shares for cancellation, as part of an initiative announced earlier in February 2025. This move is expected to impact the company’s share capital structure, reducing the number of shares in circulation and potentially affecting shareholder value and market perception.
Barclays PLC disclosed its positions and dealings in the securities of Dalata Hotel Group PLC, as required under the Irish Takeover Panel Act. The disclosure reveals Barclays’ interests and short positions in Dalata’s securities, indicating a strategic financial engagement with the hotel group. This involvement may influence Barclays’ market positioning and stakeholder interests in the hospitality sector.
Barclays PLC has announced the purchase and cancellation of 1,873,220 of its ordinary shares on the London Stock Exchange as part of its ongoing buy-back program initiated in February 2025. This move is expected to reduce the company’s share capital to 14,250,506,236 ordinary shares, potentially impacting shareholder calculations and market perceptions, while reinforcing Barclays’ commitment to returning value to its shareholders.
Barclays PLC has disclosed its interests and short positions in the securities of Dalata Hotel Group PLC, as required under Rule 8.3 of the Irish Takeover Panel Act. The disclosure reveals that Barclays holds a total of 2,337,179 shares, representing 1.11% of the relevant securities, and has short positions amounting to 2,401,756 shares, or 1.14%. This announcement is significant as it provides transparency regarding Barclays’ investment activities related to Dalata Hotel Group, which could impact stakeholders’ perceptions and the company’s strategic positioning within the market.
Barclays PLC has announced the purchase and cancellation of 1,891,914 of its ordinary shares from J.P. Morgan Securities plc as part of its ongoing share buy-back program. This move, part of a larger initiative announced in February 2025, aims to reduce the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests. Following this transaction, Barclays’ issued share capital will consist of 14,252,360,262 ordinary shares with voting rights, which stakeholders can use for notification obligations under regulatory guidelines.